John B Gross. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » Antiviral Agents/therapeutic useDisease ProgressionDose-Response Relationship, DrugDrug Administration ScheduleDrug Therapy, CombinationFemaleHepatitis C, Chronic/complicationsHepatitis C, Chronic/diagnosisHepatitis C, Chronic/drug therapyHumansInterferon alpha-2Interferon-alpha/therapeutic useLiver Cirrhosis/drug therapyLiver Cirrhosis/physiopathologyLiver Cirrhosis/virologyLiver Function TestsLong-Term CareMalePrognosisRandomized Controlled Trials as TopicRecombinant ProteinsRisk AssessmentSeverity of Illness IndexTreatment Outcome
Substances： See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant Proteins
Year: 2007 PMID： 17445750 DOI： 10.1016/j.cgh.2007.02.005
Source DB: PubMed Journal: Clin Gastroenterol Hepatol ISSN： 1542-3565 Impact factor: 11.382